DK1357910T3 - Fremgangsmåde til forebyggelse og behandling af smerter i de indre organer og mavetarmlidelser - Google Patents

Fremgangsmåde til forebyggelse og behandling af smerter i de indre organer og mavetarmlidelser

Info

Publication number
DK1357910T3
DK1357910T3 DK02700218T DK02700218T DK1357910T3 DK 1357910 T3 DK1357910 T3 DK 1357910T3 DK 02700218 T DK02700218 T DK 02700218T DK 02700218 T DK02700218 T DK 02700218T DK 1357910 T3 DK1357910 T3 DK 1357910T3
Authority
DK
Denmark
Prior art keywords
pain
procedures
prevention
treatment
internal organs
Prior art date
Application number
DK02700218T
Other languages
Danish (da)
English (en)
Inventor
Maria Chovet
Laurent Diop
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1357910T3 publication Critical patent/DK1357910T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02700218T 2001-01-26 2002-01-25 Fremgangsmåde til forebyggelse og behandling af smerter i de indre organer og mavetarmlidelser DK1357910T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01400214A EP1226820A1 (en) 2001-01-26 2001-01-26 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
EP02700218A EP1357910B1 (en) 2001-01-26 2002-01-25 Method for preventing and treating visceral pain and gastrointestinal disorders
PCT/EP2002/001351 WO2002058680A2 (en) 2001-01-26 2002-01-25 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders

Publications (1)

Publication Number Publication Date
DK1357910T3 true DK1357910T3 (da) 2005-08-08

Family

ID=8182608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02700218T DK1357910T3 (da) 2001-01-26 2002-01-25 Fremgangsmåde til forebyggelse og behandling af smerter i de indre organer og mavetarmlidelser

Country Status (22)

Country Link
US (2) US6784208B2 (ja)
EP (3) EP1226820A1 (ja)
JP (2) JP2004517147A (ja)
KR (1) KR20030070140A (ja)
CN (1) CN1610544A (ja)
AR (1) AR036009A1 (ja)
AT (1) ATE293968T1 (ja)
BR (1) BR0206687A (ja)
CA (1) CA2435950A1 (ja)
DE (1) DE60203878T2 (ja)
DK (1) DK1357910T3 (ja)
ES (1) ES2240686T3 (ja)
IL (2) IL156667A0 (ja)
MX (1) MXPA03006723A (ja)
NZ (1) NZ526625A (ja)
PE (1) PE20020832A1 (ja)
PL (1) PL363354A1 (ja)
PT (1) PT1357910E (ja)
SI (1) SI1357910T1 (ja)
TW (1) TWI223593B (ja)
WO (1) WO2002058680A2 (ja)
ZA (2) ZA200305590B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528151A (en) * 2001-04-19 2005-04-29 Warner Lambert Co Fused bicyclic or tricyclic amino acids
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
WO2006056874A1 (en) * 2004-11-25 2006-06-01 Pfizer Limited Salt form
CN118370746A (zh) * 2024-04-25 2024-07-23 江苏省中医院 马尿酸在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
HUP0004310A3 (en) * 1997-10-27 2001-11-28 Warner Lambert Co Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
EP1031350A1 (en) * 1999-02-23 2000-08-30 Warner-Lambert Company Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
NZ528151A (en) * 2001-04-19 2005-04-29 Warner Lambert Co Fused bicyclic or tricyclic amino acids

Also Published As

Publication number Publication date
WO2002058680A2 (en) 2002-08-01
IL156667A0 (en) 2004-01-04
MXPA03006723A (es) 2003-10-24
DE60203878D1 (de) 2005-06-02
ZA200407412B (en) 2005-06-29
AR036009A1 (es) 2004-08-04
PL363354A1 (en) 2004-11-15
US20040266876A1 (en) 2004-12-30
TWI223593B (en) 2004-11-11
EP1357910A2 (en) 2003-11-05
BR0206687A (pt) 2004-02-03
KR20030070140A (ko) 2003-08-27
JP2004517147A (ja) 2004-06-10
PE20020832A1 (es) 2002-10-03
ES2240686T3 (es) 2005-10-16
CA2435950A1 (en) 2002-08-01
IL164012A0 (en) 2005-12-18
CN1610544A (zh) 2005-04-27
WO2002058680A3 (en) 2002-09-19
DE60203878T2 (de) 2006-02-16
EP1226820A1 (en) 2002-07-31
US20020161047A1 (en) 2002-10-31
EP1357910B1 (en) 2005-04-27
EP1514541A1 (en) 2005-03-16
US6784208B2 (en) 2004-08-31
JP2005015492A (ja) 2005-01-20
ATE293968T1 (de) 2005-05-15
NZ526625A (en) 2004-12-24
SI1357910T1 (ja) 2005-08-31
ZA200305590B (en) 2004-10-18
PT1357910E (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
DK1793855T4 (da) Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
IS8004A (is) Aðferð við meðhöndlun á vægri vitsmunaskerðingu og til að fyrirbyggja eða tefja Alzheimers-sjúkdóminn
DK1678194T3 (da) Modulering af syntese og degradering af hyaluronan i behandlingen af sygdom
DK1286668T3 (da) Farmaceutiske kombinationer indeholdende tegaserod og omeprazol og deres anvendelse til behandling af gastrointestinale sygdomme
DE60237823D1 (de) Medizinisches behandlungsinstrument
DK1673104T3 (da) Fremføring af terapeutiske forbindelser til hjernen og andre væv
DK1423102T3 (da) Plaster til behandling af neglevæksts dysfunktioner og lidelser
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
NO20052699D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20052698D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
DK1411064T3 (da) Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer
IS8359A (is) Vefjaverndandi frumuboðar til meðferðar og forvarnar á blóðeitrun og samloðunarmyndun
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
ZA200410157B (en) Methods of treating gastrointestinal and genitorinary pain disorders using vanilafaxin and derivatives
DE60230328D1 (de) Boot zur wärmebehandlung und vertikalwärmebehandlungsgerät
DK1357910T3 (da) Fremgangsmåde til forebyggelse og behandling af smerter i de indre organer og mavetarmlidelser
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
DK1341786T3 (da) Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander